FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

900000000000509007: United States of America English language reference set (foundation metadata concept)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Id Description Lang Type Status Case? Module
900000000001115012 United States of America English language reference set en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001116013 US English en Synonym (core metadata concept) Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)
900000000001117016 United States of America English language reference set (foundation metadata concept) en Fully specified name Active Entire term case sensitive (core metadata concept) SNOMED CT model component module (core metadata concept)


1326181 members. Search Members:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
US English Is a English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept) true Inferred relationship Some

Members acceptabilityId
pN1mi(sn) (UICC) Preferred (foundation metadata concept)
pN1mi: Micrometastasis (greater than 0.2 mm, none greater than 2.0 mm) (breast) Preferred (foundation metadata concept)
pN1mi: Micrometastasis (greater than 0.2 mm, none greater than 2.0 mm) (breast) (finding) Preferred (foundation metadata concept)
pN2 (AJCC) Preferred (foundation metadata concept)
pN2 (IVA): Bilateral regional lymph node metastasis (pT1-pT4) (TNM category and FIGO stage) (vulva) Preferred (foundation metadata concept)
pN2 (IVA): Bilateral regional lymph node metastasis (pT1-pT4) (TNM category and FIGO stage) (vulva) (finding) Preferred (foundation metadata concept)
pN2 (IVB): Bilateral regional lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vulva) Preferred (foundation metadata concept)
pN2 (IVB): Bilateral regional lymph node metastasis (pT1-pT4, pM1) (TNM category and FIGO stage) (vulva) (finding) Preferred (foundation metadata concept)
pN2 (UICC) Preferred (foundation metadata concept)
pN2 category Preferred (foundation metadata concept)
pN2 category (finding) Preferred (foundation metadata concept)
pN2 stage Acceptable (foundation metadata concept)
pN2(sn) (UICC) Preferred (foundation metadata concept)
pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa (nasopharynx) Preferred (foundation metadata concept)
pN2: Bilateral metastasis in lymph node(s), 6 cm or less in greatest dimension, above the supraclavicular fossa (nasopharynx) (finding) Preferred (foundation metadata concept)
pN2: Bilateral regional lymph node metastasis (vulva) Preferred (foundation metadata concept)
pN2: Bilateral regional lymph node metastasis (vulva) (finding) Preferred (foundation metadata concept)
pN2: Metastasis in 2 to 3 regional nodes or intralymphatic regional metastasis without nodal metastasis (melanoma of the skin) Preferred (foundation metadata concept)
pN2: Metastasis in 2 to 3 regional nodes or intralymphatic regional metastasis without nodal metastasis (melanoma of the skin) (finding) Preferred (foundation metadata concept)
pN2: Metastasis in 4 or more regional lymph nodes (colon/rectum) Preferred (foundation metadata concept)
pN2: Metastasis in 4 or more regional lymph nodes (colon/rectum) (finding) Preferred (foundation metadata concept)
pN2: Metastasis in 4 to 9 axillary lymph nodes, or in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis (breast) Preferred (foundation metadata concept)
pN2: Metastasis in 4 to 9 axillary lymph nodes, or in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis (breast) (finding) Preferred (foundation metadata concept)
pN2: Metastasis in 7 to 15 regional (perigastric) lymph nodes (stomach) Preferred (foundation metadata concept)
pN2: Metastasis in 7 to 15 regional (perigastric) lymph nodes (stomach) (finding) Preferred (foundation metadata concept)
pN2: Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, none more than 5 cm in greatest dimension (urinary bladder, ureter, renal pelvis) Preferred (foundation metadata concept)
pN2: Metastasis in a single lymph node, more than 2 cm but not more than 5 cm in greatest dimension; or multiple lymph nodes, none more than 5 cm in greatest dimension (urinary bladder, ureter, renal pelvis) (finding) Preferred (foundation metadata concept)
pN2: Metastasis in more than one regional lymph node (kidney) Preferred (foundation metadata concept)
pN2: Metastasis in more than one regional lymph node (kidney) (finding) Preferred (foundation metadata concept)
pN2: Metastasis in the subcarinal lymph node(s) and/or the ipsilateral internal mammary or mediastinal lymph node(s) (thoracic mesothelioma) Preferred (foundation metadata concept)
pN2: Metastasis in the subcarinal lymph node(s) and/or the ipsilateral internal mammary or mediastinal lymph node(s) (thoracic mesothelioma) (finding) Preferred (foundation metadata concept)
pN2: Metastasis in unilateral internal iliac AND/OR inguinal lymph node(s) (anal canal) Preferred (foundation metadata concept)
pN2: Metastasis in unilateral internal iliac AND/OR inguinal lymph node(s) (anal canal) (finding) Preferred (foundation metadata concept)
pN2: Metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes(s) (lung) Preferred (foundation metadata concept)
pN2: Metastasis to ipsilateral mediastinal and/or subcarinal lymph nodes(s) (lung) (finding) Preferred (foundation metadata concept)
pN2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or more than 5 nodes positive, none more than 5 cm; or evidence of extranodal extension of tumor (testis) Preferred (foundation metadata concept)
pN2: Metastasis with a lymph node mass more than 2 cm but not more than 5 cm in greatest dimension; or more than 5 nodes positive, none more than 5 cm; or evidence of extranodal extension of tumor (testis) (finding) Preferred (foundation metadata concept)
pN2a (AJCC) Preferred (foundation metadata concept)
pN2a (UICC) Preferred (foundation metadata concept)
pN2a category Preferred (foundation metadata concept)
pN2a category (finding) Preferred (foundation metadata concept)
pN2a(sn) (UICC) Preferred (foundation metadata concept)
pN2a: Clinically occult (microscopic) metastasis (melanoma of the skin) Preferred (foundation metadata concept)
pN2a: Clinically occult (microscopic) metastasis (melanoma of the skin) (finding) Preferred (foundation metadata concept)
pN2a: Metastasis in 4 to 9 axillary lymph nodes (at least one tumor deposit greater than 2.0 mm) (breast) Preferred (foundation metadata concept)
pN2a: Metastasis in 4 to 9 axillary lymph nodes (at least one tumor deposit greater than 2.0 mm) (breast) (finding) Preferred (foundation metadata concept)
pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension (upper aerodigestive tract) Preferred (foundation metadata concept)
pN2a: Metastasis in a single ipsilateral lymph node, more than 3 cm but not more than 6 cm in greatest dimension (upper aerodigestive tract) (finding) Preferred (foundation metadata concept)
pN2b (AJCC) Preferred (foundation metadata concept)
pN2b (UICC) Preferred (foundation metadata concept)
pN2b category Preferred (foundation metadata concept)
pN2b category (finding) Preferred (foundation metadata concept)
pN2b(sn) (UICC) Preferred (foundation metadata concept)
pN2b: Clinically apparent (macroscopic) metastasis (melanoma of the skin) Preferred (foundation metadata concept)
pN2b: Clinically apparent (macroscopic) metastasis (melanoma of the skin) (finding) Preferred (foundation metadata concept)
pN2b: Metastasis in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis (breast) Preferred (foundation metadata concept)
pN2b: Metastasis in clinically apparent internal mammary lymph nodes in the absence of axillary lymph node metastasis (breast) (finding) Preferred (foundation metadata concept)
pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension (upper aerodigestive tract) Preferred (foundation metadata concept)
pN2b: Metastasis in multiple ipsilateral lymph nodes, none more than 6 cm in greatest dimension (upper aerodigestive tract) (finding) Preferred (foundation metadata concept)
pN2c (AJCC) Preferred (foundation metadata concept)
pN2c (UICC) Preferred (foundation metadata concept)
pN2c category Preferred (foundation metadata concept)
pN2c category (finding) Preferred (foundation metadata concept)
pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension (upper aerodigestive tract) Preferred (foundation metadata concept)
pN2c: Metastasis in bilateral or contralateral lymph nodes, none more than 6 cm in greatest dimension (upper aerodigestive tract) (finding) Preferred (foundation metadata concept)
pN2c: Satellite or in-transit metastasis without nodal metastasis (melanoma of the skin) Preferred (foundation metadata concept)
pN2c: Satellite or in-transit metastasis without nodal metastasis (melanoma of the skin) (finding) Preferred (foundation metadata concept)
pN2mi (AJCC) Preferred (foundation metadata concept)
pN2mi (UICC) Preferred (foundation metadata concept)
pN3 (AJCC) Preferred (foundation metadata concept)
pN3 (UICC) Preferred (foundation metadata concept)
pN3 category Preferred (foundation metadata concept)
pN3 category (finding) Preferred (foundation metadata concept)
pN3 stage Acceptable (foundation metadata concept)
pN3: Metastasis in a lymph node(s), more than 6 cm in dimension, and/or to supraclavicular fossa (nasopharynx) Preferred (foundation metadata concept)
pN3: Metastasis in a lymph node(s), more than 6 cm in dimension, and/or to supraclavicular fossa (nasopharynx) (finding) Preferred (foundation metadata concept)
pN3: Metastasis in a lymph node, more than 5 cm in greatest dimension (urinary bladder, ureter, renal pelvis) Preferred (foundation metadata concept)
pN3: Metastasis in a lymph node, more than 5 cm in greatest dimension (urinary bladder, ureter, renal pelvis) (finding) Preferred (foundation metadata concept)
pN3: Metastasis in a lymph node, more than 6 cm in greatest dimension (upper aerodigestive tract) Preferred (foundation metadata concept)
pN3: Metastasis in a lymph node, more than 6 cm in greatest dimension (upper aerodigestive tract) (finding) Preferred (foundation metadata concept)
pN3: Metastasis in four or more regional nodes, or matted metastatic nodes, or in-transit metastasis or satellite(s) with metastasis in regional node(s) (melanoma of the skin) Preferred (foundation metadata concept)
pN3: Metastasis in four or more regional nodes, or matted metastatic nodes, or in-transit metastasis or satellite(s) with metastasis in regional node(s) (melanoma of the skin) (finding) Preferred (foundation metadata concept)
pN3: Metastasis in more than 15 regional (perigastric) lymph nodes (stomach) Preferred (foundation metadata concept)
pN3: Metastasis in more than 15 regional (perigastric) lymph nodes (stomach) (finding) Preferred (foundation metadata concept)
pN3: Metastasis in perirectal and inguinal lymph nodes AND/OR bilateral internal iliac AND/OR inguinal lymph nodes (anal canal) Preferred (foundation metadata concept)
pN3: Metastasis in perirectal and inguinal lymph nodes AND/OR bilateral internal iliac AND/OR inguinal lymph nodes (anal canal) (finding) Preferred (foundation metadata concept)
pN3: Metastasis in the contralateral mediastinal, internal mammary, or hilar lymph node(s), and/or the ipsilateral or contralateral supraclavicular or scalene lymph node(s) (thoracic mesothelioma) Preferred (foundation metadata concept)
pN3: Metastasis in the contralateral mediastinal, internal mammary, or hilar lymph node(s), and/or the ipsilateral or contralateral supraclavicular or scalene lymph node(s) (thoracic mesothelioma) (finding) Preferred (foundation metadata concept)
pN3: Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes(s) (lung) Preferred (foundation metadata concept)
pN3: Metastasis to contralateral mediastinal, contralateral hilar, ipsilateral or contralateral scalene, or supraclavicular lymph nodes(s) (lung) (finding) Preferred (foundation metadata concept)
pN3: Metastasis with a lymph node mass more than 5 cm in greatest dimension (testis) Preferred (foundation metadata concept)
pN3: Metastasis with a lymph node mass more than 5 cm in greatest dimension (testis) (finding) Preferred (foundation metadata concept)
pN3a (AJCC) Preferred (foundation metadata concept)
pN3a (UICC) Preferred (foundation metadata concept)
pN3a category Preferred (foundation metadata concept)
pN3a category (finding) Preferred (foundation metadata concept)
pN3a: Metastasis in 10 or more axillary lymph nodes (at least one tumor deposit greater than 2.0 mm), or metastasis to infraclavicular lymph nodes (breast) Preferred (foundation metadata concept)
pN3a: Metastasis in 10 or more axillary lymph nodes (at least one tumor deposit greater than 2.0 mm), or metastasis to infraclavicular lymph nodes (breast) (finding) Preferred (foundation metadata concept)
pN3a: Metastasis in a lymph node(s), more than 6 cm in dimension (nasopharynx) Preferred (foundation metadata concept)
pN3a: Metastasis in a lymph node(s), more than 6 cm in dimension (nasopharynx) (finding) Preferred (foundation metadata concept)
pN3b (AJCC) Preferred (foundation metadata concept)

Start Previous Page 13239 of 13262 Next End


Reference Sets

Reference set descriptor

Back to Start